Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

NCT00170157 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Prostate Carcinoma
Recurrent Prostate Carcinoma
Stage III Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: Bicalutamide
DRUG: Flutamide
DRUG: Goserelin Acetate
DRUG: Ipilimumab
DRUG: Leuprolide Acetate
OTHER: Pharmacological Study

Sponsor

Mayo Clinic

Collaborators

[object Object]